Press Releases
   Company Newsletter
   Media Coverage
   Special Events
   
     
 
   
 

Current Issues - Newsletter
April 2000

 
 
 

NEWS FLASH

 
 
   
  Sabinsa Corporation Participates in European Trade Show Event  
 
 
Sabinsa Corporation participated in the trade show event, In-Cosmetics Europe, held in Barcelona, Spain from April 11th to April 13th 2000. Products from the expanding cosmeceutical line, including Tetrahydrocurcuminoids, BoswellinÒ -CG, Aleuritic acid, Green tea catechins, Rosmarinic acid, Ursolic acid, and Turmeric oil were exhibited at the show.
 
   
 

Role of Antioxidants in Chronic Disease Prevention

 
 
  The National Academy of Sciences (NAS) released a report on April 11th reviewing the emerging science of antioxidants and their potential for disease protection. As summarized by the Council for Responsible Nutrition, although the report did not conclude that scientific evidence is sufficiently consistent to permit recommended intakes based on disease prevention, it did recognize the wide range of safe intakes for antioxidant vitamins and issued higher Recommended Dietary Allowances (RDAs) for vitamins C and E. The new RDAs for antioxidant nutrients are: vitamin C (75 milligrams (mg) for women and 90 mg for men), vitamin E (15 mg), and selenium (55 micrograms (mcg)).

The report stated that there is "reason to expect that the antioxidant vitamins (C and E) should decrease the risk of cardiovascular disease." The report concluded that vitamin E does inhibit LDL oxidation (a causative agent for cardiovascular disease) and could also affect the health of arteries in other ways. The report also noted that it is reasonable to expect that vitamin C would reduce oxidative damage to the eye, thus lessening the risk of cataracts and other conditions. The NAS report also established tolerable upper intake levels (ULs) for vitamin C (2,000 mg), vitamin E (1,000 mg) and selenium (400 mcg). ULs for adults are set to protect the most sensitive individuals of the general population.

 
   
  High-selenium Food Products  
 
 

High Selenium pork: A Successful Product in Korea.

Selen pork, a special brand of high selenium pork, containing about ten times the selenium content of traditional pork is being marketed successfully in Korea. Pigs yielding this product are fed Sel-Plex, an organic selenium supplement which contains selenomethionine and other naturally-occurring organic selenium compounds.

A study performed in Spain2 reported that a combination of supplemental selenium and the antioxidant vitamins E and vitamin C in swine diets helped reduce drip loss and improve the shelf life of fresh pork products. Drip loss is a particular problem in pale, soft and exudative pork. Selenium and vitamins E and C are potential antioxidants. Vitamin E helps prevent lipids in the cell membrane from breaking down. Selenium also appears to protect the cell, preventing the fluid portion of the cytoplasm from breaking down.

In the study, University of Murcia researchers fed pigs 0.1 parts per million supplemental organic selenium. Pork from those pigs showed slightly lower drip loss for up to 120 hours after slaughter (Fig. 1).

In an additional trial, consumers rated the antioxidant-supplemented pork as juicier and more tender than pork from the control pigs that were not fed organic selenium.

  1. Agro-Industry High Tech-January/February 2000, page 41.
  2. A. Munoz, M. D. Garindo and M.V. Granados (1997) Effect of selenium yeast and vitamins C and E on pork meat exudation (cited by T.P. Lyons In: Biotechnology in the Feed Industry, 14th Annual Symposium, p. 1).
 
   
  Selenium-rich Designer Eggs  
 
  Efficient transfer of dietary selenium through the inclusion of an organic form of the trace element in laying hens’ diets opens up new possibilities for functional eggs providing this essential trace element to an increasingly health conscious world population.

Source:
The International Egg Commission Newsletter, June 1999

 
   
  FDA Withdraws Proposed Limits on Herb Ephedra  
 
 

On Friday, March 31st, 2000, Federal health officials withdrew controversial proposals to limit consumption of the herb ephedra since they plan to conduct a new review of its safety. Ephedra has been promoted as an ingredient in weight-loss products by the dietary supplements industry. The FDA has been criticized by industry members for creating unfounded concerns about this substance, based on about 273 adverse events reports from people consuming ephedra-containing products.

In 1997, based on these concerns, the FDA had proposed limiting ephedra dosages in supplements and enforcing the use of warning labels for consumers to take them for no longer than seven days because of the risk of heart attacks, strokes or other serious problems. Those proposals are now withdrawn on account of opposition from lawmakers and industry groups who contended that the FDA did not have enough scientific evidence to support the limits and had relied on anecdotal evidence. Besides, ephedra has been used for centuries in Asia and only has a mild stimulant effect comparable to caffeine, if taken in the proper manner.

As reported by Reuters, Wes Siegner, a spokesman for the Ephedra Education Council, an industry group, stated that the industry was very interested in marketing these products safely and believed in their current national standard, which includes warnings against ephedra use by people with heart problems or other conditions that make taking stimulants dangerous. The FDA, meanwhile, said it had enlisted agency officials and outside experts to review the reports of possible side effects to ephedra..

Sabinsa Corporation supplies Sida cordifolia extract standardized to contain 0.8% ephedrine.

 
   
  Immunological Effects of Lactic Acid Bacteria  
 
  A review article in the current issue of the American Journal of Clinical Nutrition details the therapeutic and preventive effects of yogurt and lactic acid bacteria on diseases such as cancer, gastrointestinal disorders, and asthma. Since the immune system is an important factor in all of these diseases, early researchers proposed that lactic acid bacteria had an immunostimulatory effect. This hypothesis was investigated by using mainly animal models and occasionally, human subjects. Although the results of these studies are not conclusive due to improper experimental design and conditions used, they do provide a strong rationale for the hypothesis that increased yogurt/active lactic cultures consumption, particularly in immuno-compromised populations such as the elderly, may enhance the immune response, which would in turn increase resistance to immune-related diseases.

American Journal of Clinical Nutrition, Vol. 71, No. 4, 861-872, April 2000

 
   
  Plant Sterols and Stanols Help to Prevent Heart Disease  
 
  According to a new clinical review1, the risk of heart disease could be reduced by 25 % by adding plant stanols or sterols to the daily diet. Plant stanols and sterols reduce the absorption of cholesterol, thereby lowering serum cholesterol levels. Plant stanols are esterified to form plant stanol esters that can be incorporated into margarines and other foods. Dr. Malcolm Law from the Wolfson Institute of Preventive Medicine and the author of the article states that just 2 g of plant stanols added to an average daily portion of margarine can reduce the risk of heart disease by effecting decrease in serum concentrations of low density lipoprotein cholesterol by an average of 0.54 mmol/L in people aged 50-59, 0.43 mmol/L in those aged 40-49, and 0.33 mmol/L in those aged 30-39.

A recent study revealed that cholesterol absorption decreased by 18% in subjects consuming soy sterol ester and by 17% when the subjects took ß-sitostanol ester, as compared to untreated controls2.

  1. BMJ 2000; 320:861-864 (25 March)

  2. Am. J. Clin. Nutr. 2000 Apr; 71(4):908-13
 
   
  Tea Drinking & Bone Mineral Density in Older Women  
 
  High caffeine intake is reported as a risk factor for reduced bone mineral density (BMD) in older women. Most studies, however, are from populations in which coffee drinking predominates and is the major caffeine source. Tea contains caffeine but also has other nutrients, such as flavonoids (catechins), that may influence bone mass in different ways. The amino acid theanine, present in tea, is also reported to counteract the stimulant effects of caffeine.

A study performed in Britain, where tea-drinking is common, measured BMD in 1256 free living women aged 65–76 years in Cambridge, United Kingdom. There were 1134 tea drinkers (90.3%) and 122 non–tea drinkers (9.7%). Compared with non–tea drinkers, tea drinkers had significantly greater (5%) mean BMD measurements, adjusted for age, and significantly greater body mass index. These findings were independent of smoking status, use of hormone replacement therapy, coffee drinking, and whether milk was added to the tea. The authors concluded that nutrients found in tea, such as flavonoids, may influence BMD and offer protection against osteoporosis in older women.

American Journal of Clinical Nutrition, Vol. 71, No. 4, 1003-1007, April 2000

 
   
  Product Focus : Tetrahydrocurcuminoids  
 
  Tetrahydrocurcuminoids (THC)*, the patent pending nutrient for topical and oral applications are color-free compounds derived from the yellow curcuminoids** (the biologically active principles extracted from the rhizomes of (Curcuma longa) (Figure 2).

The properties of THC, particularly its superior antioxidant property, combined with the lack of yellow color, render this product useful for oral (e.g. achromatic foods) and cosmetic applications that currently employ conventional synthetic antioxidants.

Oral Use

THC has been reported to be an effective antioxidant and chemopreventive agent.1 The Tetrahydrocurcuminoids’ chemopreventive properties are associated with their antioxidant effects since free radicals have been proven to be causative factors of tumor promotion.

A recent study validated the well-known superior antioxidant properties of THC and explained the mechanism of antioxidant action. In this study, the inhibitory effects of curcumin and THC were studied on the lipid peroxidation of erythrocyte membranes induced by tertbutylhydroperoxide. The results demonstrated that THC showed a greater inhibitory effect than curcumin. The authors concluded that THC must efficiently scavenge free radicals such as the tert-butoxyl radical and peroxyl radical. They also based their explanation of the tetrahydrocurcuminoids’ mechanism of antioxidant action on their molecular structure. The diketo moiety was identified as exhibiting antioxidant activity by cleavage of the C-C bond on the active methylene group (CH2-) carbon located between the carbonyls in the diketo moiety.2

Similar results were reported in another study that evaluated the comparative antioxidant activity of curcuminoids and tetrahydrocurcumin in vitro using linoleic acid as the substrate in an ethanol/water system as well as using rabbit erythrocyte membranes and rat livers. It was found that Tetrahydrocurcumin had the strongest antioxidant activity among all curcuminoids in each assay system. The authors concluded that these results must play an important role in the antioxidant mechanism of curcumin in vivo.3

Cosmetic Use

The tetrahydrocurcuminoids’ antioxidant actions are useful and important in maintaining skin health and integrity. As established, free radicals on the surface of the skin, generated thorough exposure to ultraviolet radiation, chemicals, or other environmental stress factors catalyze aging of the skin. The tetrahydrocurcuminoids’ precursors, the curcuminoids, have been validated as topical antioxidants in laboratory experiments. Curcuminoids are reported to protect normal human keratinocytes from hypoxanthine/xanthine injury in in vitro studies. This study suggests that curcuminoids and therefore THC offer protection to the skin and could be included as functional antioxidants in topical applications.4 Added benefits of THC are its anti-inflammatory5,6 action and ability to improve the shelf-life of fat-based topical formulations by inhibiting the auto-oxidation of fats.

  1. Kim et al. (1998) Carcinogenesis, 19(1), 81-85.

  2. Sugiyama et al. (1996) Biochem. Pharmacol., 52(4), 519-525.

  3. Huang et al. (1997) J. Cell. Biochem. Suppl., 27, 26-34.

  4. Bonté et al. (1997) Planta Medica, 63(3), 256-266.

  5. Mukhopadhaya et al. (1982) 12, 2287.

  6. Rao et al. (1982) Ind. J. Med. Res., 75, 574-578.

    ** Patent granted for curcuminoids and its derivative, e.g. THC, US Patent #5,861,415

    * Patent Pending

 
   
  People focus: Helen Ricalde  
 
 
Helen Ricalde recently joined Sabinsa’s New Jersey office as Manager, Quality Assurance/Quality Control. She graduated from Rutgers University in May 1999 with a Bachelor’s degree in Food Science and Biological Sciences. Before joining Sabinsa, Helen gained valuable experience at McNeil Specialty Products Company, a division of Johnson & Johnson, participating in research on sucralose. While in school, she worked as a Laboratory Assistant at Dragoco, an international flavor and fragrance manufacturer. She had also been a Research Assistant at Cook College’s Department of Food Science, participating in studies involving virulence mechanisms of E. coli 0157:H7. We take this opportunity to welcome Helen aboard!
 
   
  Sabinsa's upcoming shows  
 
  Sabinsa Corporation will participate in the following Trade Show Events in May 2000.

May 3-5, 2000:
Vitafoods International at PalExpo Convention Center (Geneva, Switzerland)
Booth #1570

May 8-10, 2000:
Supply Side East at Meadowlands Convention Center (Secaucus, NJ)
Booth #613

May 16-17, 2000:
NY Society of Cosmetic Chemists Suppliers Day Event at Meadowlands Convention Center (Secaucus, NJ)
Booth #116

 
     
 
"The information presented in the "Current Issues" Newsletter from Sabinsa Corporation is for informational purposes only. It is abstracted from web and print media sources. Readers are advised to refer to the original sources for additional information".
 
   
Copyright © 2007 Sabinsa Corporation All Rights Reserved